MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Total Assets 2011-2026 | SYK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.8 B | 43 B | 39.9 B | 36.9 B | 34.6 B | 34.3 B | 30.2 B | 27.2 B | 22.2 B | 20.4 B | 16.2 B | 17.7 B | 15.7 B | 13.2 B | 12.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.8 B | 12.4 B | 27.5 B |
Quarterly Total Assets Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 B | 46.3 B | 46 B | 43.8 B | 39.1 B | 39.4 B | 38 B | 37.4 B | 36.8 B | 36.9 B | 36 B | - | 36.1 B | 34.6 B | 34.1 B | 33.7 B | 33.5 B | 34.3 B | 34.3 B | 34.3 B | 34.3 B | 30.2 B | 30.2 B | 30.2 B | 30.2 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 22.2 B | 22.2 B | 22.2 B | 22.2 B | 20.4 B | 20.4 B | 20.4 B | 20.4 B | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 17.3 B | 17.7 B | 17.7 B | 17.7 B | 15.4 B | 15.7 B | 15.7 B | 15.7 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 12.1 B | 12.4 B | 12.4 B | 12.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.1 B | 12.1 B | 26 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.21 | 3.27 % | $ 3.45 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 10.61 | 1.82 % | $ 1.43 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.22 | 7.66 % | $ 893 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 12.88 | 2.18 % | $ 1.93 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 8.38 | - | $ 602 M |  Israel |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 71.53 | 2.49 % | $ 106 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.2 | -0.53 % | $ 1.15 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.69 | 6.49 % | $ 37.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.07 | 2.73 % | $ 152 M |  France |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Establishment Labs Holdings
ESTA
|
357 M | $ 65.28 | 2.84 % | $ 1.93 B |  Costa-rica |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 11.22 | 1.68 % | $ 303 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
199 M | $ 18.43 | 0.05 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.21 | 0.68 % | $ 1.34 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.33 | -0.38 % | $ 21.5 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
766 M | $ 13.65 | 1.64 % | $ 882 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 111.3 | 1.23 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.85 | 0.41 % | $ 353 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 269.14 | 3.09 % | $ 7.59 B | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.17 | 2.83 % | $ 3.45 B |  Britain |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.22 | 2.33 % | $ 710 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 4.43 | 0.34 % | $ 655 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 32.73 | -0.33 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 177.7 | 4.87 % | $ 13.3 B | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 33.88 | 3.4 % | $ 5.05 K | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
66.8 M | $ 3.81 | 3.81 % | $ 157 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 17.34 | 1.34 % | $ 407 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 86.55 | 2.89 % | $ 3.01 B | USA |